M K Proteins schedules 14th AGM for September 30, 2026
- M K Proteins fixes 14th AGM for September 30, 2026
- Meeting to be held via video conference or audio-visual means
- Book closure runs from September 24 to September 30, 2026
- Board approved notice and directors report for FY26

*this image is generated using AI for illustrative purposes only.
M K Proteins has scheduled its 14th Annual General Meeting for September 30, 2026. The board approved the notice and directors report for the fiscal year ended March 31, 2026.
The company informed the Bombay Stock Exchange and National Stock Exchange that the meeting will be held via video conference or other audio-visual means. This arrangement complies with circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.
Corporate Action Details
The board meeting commenced at 3:00 pm and concluded at 3:30 pm on September 2, 2026. Directors approved the following items:
- Notice of the 14th Annual General Meeting
- Directors Report along with annexures
The notice of the AGM and the annual report will be dispatched to shareholders and stock exchanges separately in due course.
Book Closure Period
Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the register of members and share transfer books will remain closed.
| Event | Date |
|---|---|
| Book Closure Start | September 24, 2026 |
| Book Closure End | September 30, 2026 |
| AGM Date | September 30, 2026 |
The closure period includes both start and end dates. Shareholders on record during this window will be eligible to attend the meeting and vote on resolutions.
Historical Stock Returns for MK Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.74% | -2.91% | -4.31% | -21.26% | -37.98% | 0.0% |
What specific financial performance metrics or strategic initiatives are expected to be highlighted in the Directors Report for FY2026?
How might the outcomes of the AGM resolutions impact M K Proteins' dividend policy or capital allocation strategy for the upcoming fiscal year?
Are there any proposed changes to the board composition or executive compensation that shareholders will be voting on during the meeting?


































